Monoclonal Antibody Reduced Proteinuria in IgA Nephropathy

By News Health
2 hours Ago

(MedPage Today) — At the American Society of Nephrology (ASN) Kidney Week meeting, an interim analysis of a phase III trial of sibeprenlimab in immunoglobulin A (IgA) nephropathy showed a nearly 50% reduction in proteinuria at 9 months, with favorable…

Source link : https://www.medpagetoday.com/meetingcoverage/kidneyweekvideopearls/118651

Author :

Publish date : 2025-11-21 19:13:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Telehealth-Based Cancer Trial; AI-Based Cancer Biomarkers; Myeloma Survival Landmark

Cardiologists Still Have Little Idea Who Is Going to Have a Heart Attack

UK at Risk of Driving Out International Doctors, GMC Warns

New Play Looking at Friendship Between Anthony Fauci and AIDS Activist in the Works

Black Women Shouldn't Have to Engineer Their Survival in the Delivery Room

Plea of non-smoker from Hastings diagnosed with lung cancer at 37